Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 970 across all filing types
Latest filing 2021-08-31 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
上海锦天城（青岛）律师事务所-关于烟台正海生物科技股份有限公司2021年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and validity of the convening, attendance, and voting procedures of the 2021 first extraordinary general meeting (临时股东大会) of Yantai Zhenghai Biotechnology Co., Ltd. It details the qualifications of the convener, attendees, the agenda, and the voting results. The document does not contain financial statements or performance data but focuses on the legal compliance of the shareholder meeting and its resolutions. This type of document is not an annual report, earnings release, or management report but a legal opinion related to a shareholder meeting. It is not a simple announcement but a formal legal opinion letter. Therefore, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory and compliance documents that do not fit other categories.
2021-08-31 Chinese
关于使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is titled '现金管理进展公告' which translates to 'Cash Management Progress Announcement'. It details the company's use of idle funds for cash management, including purchasing financial products, approval procedures, risk control measures, and impact on the company. It references board and shareholder meetings approving the use of funds for cash management but does not contain financial statements or comprehensive financial analysis. The document is about the progress and updates on cash management activities rather than a full financial report or earnings release. It is an announcement of ongoing financing activities related to cash management and investment of idle funds. Therefore, it fits best under 'Capital/Financing Update (CAP)' which covers updates on company fundraising, financing activities, or capital structure changes. The document length is about 4989 characters, sufficient for a detailed announcement but not a full report. Hence, the classification is CAP with high confidence.
2021-08-26 Chinese
关于召开2021年第一次临时股东大会的提示性公告
AGM Information Classification · 95% confidence The document is titled as a "股东大会提示性公告" which translates to "Shareholders' Meeting Reminder Announcement." It details the scheduling, procedures, and logistics for the 2021 first extraordinary shareholders' meeting, including voting methods, registration, and agenda items. It does not contain financial statements or detailed financial analysis but serves as a notice or reminder about the upcoming shareholders' meeting. The document length is about 5,085 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication that this is the actual meeting materials or minutes, but rather a preparatory announcement. Therefore, this fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or related to the Annual General Meeting or other shareholders' meetings, including notices and reminders.
2021-08-26 Chinese
关于公司申报医疗器械注册获得受理的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acceptance of a medical device registration application by a regulatory authority (Shandong Provincial Drug Administration). It details the product information, current approval stage, subsequent approval process, market background, and potential impact on the company. The document is short (1374 characters) and serves as a formal notification of a regulatory milestone rather than a financial report or detailed filing. It does not contain financial data, management changes, voting results, or other report types defined in the filing categories. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-08-09 Chinese
2021年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2021 年半年度报告全文" which translates to "2021 Semi-Annual Report Full Text" for 烟台正海生物科技股份有限公司. It contains detailed financial data, management discussion and analysis, company overview, product information, risk factors, and operational details for the period January 1, 2021 to June 30, 2021. The document length is about 15,000 characters, indicating a comprehensive report rather than a brief announcement. It includes financial metrics such as revenue, net profit, earnings per share, and detailed business and operational analysis. The presence of financial statements and substantive financial data confirms it is a financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-08-05 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is titled '董事会决议公告' which translates to 'Board of Directors Resolution Announcement'. It details the resolutions passed at the company's board meeting held on August 5, 2021, including approval of the 2021 semi-annual report and other related matters. The document includes voting results and references to other reports disclosed on the regulatory website but does not contain the full reports themselves. The content focuses on board decisions and meeting outcomes rather than full financial statements or detailed management discussion. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short (1526 characters), consistent with an announcement rather than a full report.
2021-08-05 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.